These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 7954867)

  • 21. Specific localization and imaging of amyloid deposits in vivo using 123I-labeled serum amyloid P component.
    Hawkins PN; Myers MJ; Epenetos AA; Caspi D; Pepys MB
    J Exp Med; 1988 Mar; 167(3):903-13. PubMed ID: 3351437
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Renal transplantation for amyloid end-stage renal failure-insights from serial serum amyloid P component scintigraphy.
    Gillmore JD; Madhoo S; Pepys MB; Hawkins PN
    Nucl Med Commun; 2000 Aug; 21(8):735-40. PubMed ID: 11039456
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative analysis of peptide p5 and serum amyloid P component for imaging AA amyloid in mice using dual-isotope SPECT.
    Wall JS; Richey T; Williams A; Stuckey A; Osborne D; Martin E; Kennel SJ
    Mol Imaging Biol; 2012 Aug; 14(4):402-7. PubMed ID: 22042488
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Micro-imaging of amyloid in mice.
    Wall JS; Paulus MJ; Gleason S; Gregor J; Solomon A; Kennel SJ
    Methods Enzymol; 2006; 412():161-82. PubMed ID: 17046658
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Iodine-123-labelled serum amyloid P component scintigraphy in amyloidosis.
    Saïle R; Deveaux M; Hachulla E; Descamps J; Duquesnoy B; Marchandise X
    Eur J Nucl Med; 1993 Feb; 20(2):130-7. PubMed ID: 8440269
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative evaluation of p5+14 with SAP and peptide p5 by dual-energy SPECT imaging of mice with AA amyloidosis.
    Martin EB; Williams A; Richey T; Stuckey A; Heidel RE; Kennel SJ; Wall JS
    Sci Rep; 2016 Mar; 6():22695. PubMed ID: 26936002
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circulating serum amyloid P component is the precursor of amyloid P component in tissue amyloid deposits.
    Baltz ML; Caspi D; Evans DJ; Rowe IF; Hind CR; Pepys MB
    Clin Exp Immunol; 1986 Dec; 66(3):691-700. PubMed ID: 3568456
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Scintigraphic methods to detect beta2-microglobulin associated amyloidosis (Abeta2-microglobulin amyloidosis).
    Floege J; Schäffer J; Koch KM
    Nephrol Dial Transplant; 2001; 16 Suppl 4():12-6. PubMed ID: 11402091
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Imaging of haemodialysis-associated amyloidosis with 123I-serum amyloid P component.
    Nelson SR; Hawkins PN; Richardson S; Lavender JP; Sethi D; Gower PE; Pugh CW; Winearls CG; Oliver DO; Pepys MB
    Lancet; 1991 Aug; 338(8763):335-9. PubMed ID: 1677697
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Scintigraphy of iodine 123 labelled serum amyloid P component in beta 2-microglobulin amyloidosis of hemodialysis].
    Flipo RM; Deveaux M; Duneton O; Foissac-Gegoux P; Dumont A; Duquesnoy B; Marchandise X
    Nephrologie; 1995; 16(6):419-25. PubMed ID: 8524449
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Localized or systemic amyloidosis? Value and limitations of Iodine-123 labelled amyloid P component scintigraphy, role of biopsy of minor salivary glands].
    Hachulla E; Wechsler B; Deveaux M; Godeau P; Hatron PY; Devulder B; Janin A; Marchandise X
    Rev Med Interne; 1994 Mar; 15(3):182-5. PubMed ID: 8059132
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Pentraxins 1975-2018: Serendipity, Diagnostics and Drugs.
    Pepys MB
    Front Immunol; 2018; 9():2382. PubMed ID: 30459761
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of 99mTc-MAMA-chrysamine G as an in vivo probe for amyloidosis.
    Dezutter NA; Landman WJ; Jager PL; de Groot TJ; Dupont PJ; Tooten PC; Zekarias B; Gruys E; Verbruggen AM
    Amyloid; 2001 Sep; 8(3):202-14. PubMed ID: 11676297
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnostic radionuclide imaging of amyloid: biological targeting by circulating human serum amyloid P component.
    Hawkins PN; Myers MJ; Lavender JP; Pepys MB
    Lancet; 1988 Jun; 1(8600):1413-8. PubMed ID: 2898580
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term survival in systemic amyloid A amyloidosis complicating Crohn's disease.
    Lovat LB; Madhoo S; Pepys MB; Hawkins PN
    Gastroenterology; 1997 Apr; 112(4):1362-5. PubMed ID: 9098022
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapeutic Clearance of Amyloid by Antibodies to Serum Amyloid P Component.
    Richards DB; Cookson LM; Berges AC; Barton SV; Lane T; Ritter JM; Fontana M; Moon JC; Pinzani M; Gillmore JD; Hawkins PN; Pepys MB
    N Engl J Med; 2015 Sep; 373(12):1106-14. PubMed ID: 26176329
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnostic performance and prognostic value of extravascular retention of 123I-labeled serum amyloid P component in systemic amyloidosis.
    Hazenberg BP; van Rijswijk MH; Lub-de Hooge MN; Vellenga E; Haagsma EB; Posthumus MD; Jager PL
    J Nucl Med; 2007 Jun; 48(6):865-72. PubMed ID: 17504868
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Unicentric Castleman's disease complicated by systemic AA amyloidosis: a curable disease.
    Lachmann HJ; Gilbertson JA; Gillmore JD; Hawkins PN; Pepys MB
    QJM; 2002 Apr; 95(4):211-8. PubMed ID: 11937647
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antibodies to human serum amyloid P component eliminate visceral amyloid deposits.
    Bodin K; Ellmerich S; Kahan MC; Tennent GA; Loesch A; Gilbertson JA; Hutchinson WL; Mangione PP; Gallimore JR; Millar DJ; Minogue S; Dhillon AP; Taylor GW; Bradwell AR; Petrie A; Gillmore JD; Bellotti V; Botto M; Hawkins PN; Pepys MB
    Nature; 2010 Nov; 468(7320):93-7. PubMed ID: 20962779
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.